Testing effectiveness (Phase 2)Ended earlyNCT04628481
What this trial is testing
Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function
Who this might be right for
Recent Onset type1 Diabetes
Dompé Farmaceutici S.p.A 289
Showing 20 of 0 results